J. Villablanca

S. Groshen, R. Hawkins, J. Maris, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study

S. Groshen, R. Hawkins, J. Maris, 2015 .

Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.

S. Groshen, C. Mari Aparici, R. Hawkins, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Iodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.

S. Groshen, R. Hawkins, B. Franc, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Successful multimodality therapy of recurrent multifocal juvenile granulosa cell tumor of the ovary.

R. Lavey, A. Erdreich-Epstein, J. Villablanca, 2002, Journal of pediatric hematology/oncology.

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.

K. McHugh, F. Berthold, O. W. Lindwasser, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Escalating dose of continuous infusion combination chemotherapy for refractory neuroblastoma.

K. Matthay, R. Seeger, J. Villablanca, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High‐dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors

J. Finlay, A. Erdreich-Epstein, J. Villablanca, 2009, Cancer.

Esthesioneuroblastoma in the pediatric age-group: the role of chemotherapy and autologous bone marrow transplantation.

J. Villablanca, S. Siegel, D. Crockett, 1996, International journal of pediatric otorhinolaryngology.

Approaches to Treatment for Extraocular Retinoblastoma: Children's Hospital Los Angeles Experience

A. Erdreich-Epstein, J. Villablanca, R. Jubran, 2004, Journal of pediatric hematology/oncology.

Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid.

J. Villablanca, C. Reynolds, V. Avramis, 1993, The American journal of pediatric hematology/oncology.

Surveillance imaging in children with medulloblastoma (posterior fossa PNET)

J. Villablanca, D. Roebuck, K. Maher, 2000, Pediatric Radiology.

Phase 1 study of concurrent RMP‐7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas

M. Mehta, G. Reaman, R. Packer, 2005, Cancer.

Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector--producer cells followed by intravenous ganciclovir administration

R. Packer, P. Cogen, G. Vezina, 2000 .

Long-term quality of life and neuropsychologic functioning for patients with CNS germ-cell tumors: from the First International CNS Germ-Cell Tumor Study.

H. Weiner, M. Pietanza, J. Finlay, 2001, Neuro-oncology.

A randomized phase III trial of myeloablative autologous peripheral blood stem cell (PBSC) transplant (ASCT) for high-risk neuroblastoma (HR-NB) employing immunomagnetic purged (P) versus unpurged (UP) PBSC: A Children’s Oncology Group study

J. Maris, S. Grupp, K. Matthay, 2008 .

Thyroid and hepatic function after high‐dose 131I‐metaiodobenzylguanidine (131I‐MIBG) therapy for neuroblastoma

S. Groshen, R. Hawkins, B. Franc, 2011, Pediatric blood & cancer.

A phase I study of zoledronic acid and low‐dose cyclophosphamide in recurrent/refractory neuroblastoma: A new approaches to neuroblastoma therapy (NANT) study

S. Groshen, H. Daldrup-Link, K. Matthay, 2011, Pediatric blood & cancer.

Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study

S. Groshen, K. Matthay, R. Sposto, 2014, BMC Research Notes.

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

S. Groshen, J. Maris, K. Matthay, 2023, Nature Medicine.

Phase I study of fenretinide (4-HPR) oral powder in patients with recurrent or resistant neuroblastoma: New Approaches to Neuroblastoma Therapy (NANT) Consortium trial.

S. Groshen, J. Maris, K. Matthay, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A single‐arm study of systemic and sub‐Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231)

C. Shields, J. O'Brien, D. Gombos, 2020, Pediatric blood & cancer.

Fenretinide (4-HPR)/Lym-X-Sorb (LXS) oral powder plus ketoconazole in patients with high-risk (HR) recurrent or resistant neuroblastoma: A New Approach to Neuroblastoma Therapy (NANT) Consortium trial.

S. Groshen, K. Matthay, Shengping Yang, 2014 .

Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration.

J. Tonn, S. Burdach, R. Packer, 1999, Journal of neurosurgery.

Extent of Lymph Node Radiation Coverage in High-Risk Neuroblastoma Does Not Affect Clinical Outcome: A Report From the COG A3973 Study

K. Matthay, A. Davidoff, D. Haas-Kogan, 2014 .

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

K. Matthay, R. Gerbing, J. Villablanca, 1999, The New England journal of medicine.

Abstract LB-049: Low plasma levels of 13-cis-retinoic acid (isotretinoin) and its active metabolite 4-oxo-13-cis-retinoic acid are associated with lower overall survival of high-risk neuroblastoma patients

A. Naranjo, Shengping Yang, J. Villablanca, 2017 .

Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

A. Naranjo, J. Maris, K. Matthay, 2013, The Journal of Nuclear Medicine.